The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 02, 2022
Filed:
Apr. 24, 2020
Livanova Usa, Inc., Houston, TX (US);
Stephen L. Bolea, Watertown, MN (US);
Thomas B. Hoegh, Edina, MN (US);
Brian D. Kuhnley, Maple Grove, MN (US);
Dale G. Suilmann, Elk River, MN (US);
Bruce J. Persson, Dresser, WI (US);
John P. Beck, Prior Lake, MN (US);
Sidney Hauschild, St. Paul, MN (US);
Paula M. Kaplan, St. Paul, MN (US);
Adam K. Hoyhtya, Shoreview, MN (US);
Wondimeneh Tesfayesus, St. Paul, MN (US);
Robert E. Atkinson, White Bear Lake, MN (US);
Peter R. Eastwood, Floreat, AU;
David R. Hillman, Nedlands, AU;
LivaNova USA, Inc., Houston, TX (US);
Abstract
An implantable neurostimulation system comprises a stimulation delivery lead and a neurostimulator. The stimulation delivery lead is coupled to an electrode. The neurostimulator is adapted to deliver a neurostimulation signal to the subject and comprises a microprocessor. The microprocessor is programmed to identify a stimulation operating window for the therapy including a first threshold and a second threshold. The second threshold comprises an awake level and an asleep level. Identifying the stimulation operating window comprises titrating a stimulation setting of the neurostimulator while the subject is awake until the first threshold and the awake level of the second threshold are identified. Identifying the stimulation operating window further comprises subsequently repeating the step of titrating the stimulation setting of the neurostimulator while the subject is asleep until the asleep level of the second threshold is identified.